﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Fri, 24 Apr 2026 15:16:36 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/August-2023/rss/1456</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/August-2023/rss/1456" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[New therapeutic agents marketed in 2022: Part 2]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-therapeutic-agents-marketed-in-2022-part-2</link><description><![CDATA[  Daniel A. Hussar, PhD  

  Daniel A. Hussar, PhD, is Dean Emeritus and Remington Professor Emeritus at the Philadelphia College of Pharmacy, Philadelphia.  

   

 Part 1 ( Pharmacy Today , ...]]></description><pubDate>Mon, 07 Aug 2023 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-therapeutic-agents-marketed-in-2022-part-2</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-1568]]></dc:identifier></item></channel></rss>